Analysis and prescriptions of acupuncture points by physiotherapists for neck pain: interrater agreement
Keywords:
Neck Pain, Traditional Chinese Medicine, Physical Therapy, RehabilitationAbstract
Objective: This study investigated the agreement between prescriptions of acupuncture points in scientific literature and pragmatic prescriptions by physiotherapists for people with neck pain. Methods: Twenty-four acupuncture points was obtained from 27
randomized controlled trials investigating the effects of acupuncture on neck pain. Fourteen raters (8 men [57%], median [min, max] time since completion of graduation and specialization courses of 18 [8, 27] and 12 [2, 25] years) reported which acupuncture points they recommend via an online questionnaire. The frequency and cooccurrence of acupuncture points prescribed were assessed, as well as both absolute and interrater agreement. Results: Physiotherapists reported 22 (of 24, 94%) acupuncture points, and (medial [min, max]) 7 [1, 16] acupuncture points individually. Most commonly point was Ashi points (n=11, 79%), Houxi SI-3 (n=10, 71%), and
Kunlun BL-60 (n=9, 64%); the most common cooccurring acupuncture points were BL60 (Kunlun) and Ashi (n=9, 64%). The interrater reliability was better-than-chance for 5 points (ranging from k=0.432, 95%CI=[0.276; 0.533] Ashi point to k=0.125, 95%CI=[0.087; 0.192] point GB21). Also, interrater agreement was worse-than-chance for 16 points (ranging from k= -0.453, 95%CI=[-0.453; -0.116] TE14 to k= -0.152, 95%CI=[-0.152; 0.000] points SI12 and GV20). Conclusion: Pragmatic prescriptions of acupuncture points for neck pain by physiotherapists experts in acupuncture do not agree with prescriptions from scientific literature. There is a need for explicit, high-level evidence-based rules for prescribing and teaching combinations of acupuncture points for neck pain to be included in future clinical trials.
Downloads
Published
Issue
Section
Categories
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.